TSL secures Canadian Permacol distributor

26 March 2006

UK-based tissue replacement and repair specialist Tissue Science Laboratories has signed a Canadian distribution agreement for the introduction of its Permacol surgical implant products in general surgery and hernia with Canadian Hospital Specialties, a leading national specialty distributor of medical supplies.

Permacol, a collagen and elastin sheet derived from porcine dermis, is a biomaterial which has a diverse range of surgical applications and is especially suited to reinforcing soft tissue and for the surgical repair of ruptured or damaged tissue. In general surgery, it is specifically indicated for the repair of abdominal wall defects and complex or recurrent hernias, the firm noted.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight